candoxatril

Candoxatril is the first drug of its kind to be released for clinical trials regarding heart failure. It is the orally active prodrug of candoxatrilat human neutral endopeptidase as the neutral endopeptidase 24. It is an orally active prodrug of candoxatrilat, a potent neutral endopeptidase inhibitor used in the treatment of chronic heart failure.. Reference standards of Candoxatril API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => Candoxatril - API Standards 
    [catalogue_number] => PA 30 74000
    [category_ids] => ,80,69,81,78,70,82,
    [chemical_name] => 
    [weight] => 515.64
    [form] => C29H41NO7
    [cas] => 123122-55-4
    [pslug] => 123122-55-4-candoxatril-api-pa3074000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)